Global Testosterone Replacement Therapy Market Size, Share, Forecast Report, 2020-2027
The global Testosterone Replacement Therapy market garnered revenue around USD 1,612.9 Million in 2019 and projected to reach USD 2,295.6 Million in 2027, with at a compound annual growth rate (CAGR) 4.5% throughout the estimate period from 2020 to 2027.
Testosterone replacement therapy (TRT) or androgen replacement therapy is one of the most important classes of hormone replacement therapy adopted globally. It involves replacement of testosterone hormone, especially in male patients, when they suffer from hypogonadism, lower testosterone levels, and/or low libido.
Several pharmaceutical manufacturing companies have introduced a wide range of TRT drugs in the global market. Key TRT drugs are available in six different product forms: gels or creams, injections, implants, patches, buccal adhesives, and orals. Key ingredients utilized in different product forms include testosterone, methyl testosterone, and testosterone esters such as testosterone undecanoate, testosterone enanthate, and testosterone cypionate.
North America was the largest market for testosterone replacement therapy in 2019 due to well-established health care infrastructure and high usage of and demand for advanced TRT products, especially in the U.S.
This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.
The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Testosterone Replacement Therapy market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Testosterone Replacement Therapy market growth.
The global Testosterone Replacement Therapy market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.
Major manufacturers analysed under this study comprises:
the global market include AbbVie, Inc., Allergan plc, Bayer AG, Endo Pharmaceuticals, Inc., Eli Lilly and Company, Kyowa Kirin International plc, Mylan N.V., Novartis AG, Pfizer, Inc., Clarus Therapeutics, and Ferring Holding SA, among others
This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:
- Global Testosterone Replacement Therapy Market, by Product Type
- Gums/Buccal Adhesives
- Global Testosterone Replacement Therapy Market, by Active Ingredient Type
- Methyl Testosterone
- Testosterone Undecanoate
- Testosterone Enanthate
- Testosterone Cypionate
Regional Analysis and Forecast
Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:
- North America
- United States
- United Kingdom
- Rest of EU
- Asia Pacific
- Southeast Asia
- Rest of APAC
- Central & South America
- Rest of Central & South America
- Middle East and Africa
- Saudi Arabia
- Rest of MEA